Jianhui Zhou

TL;DR: Results indicate that MSCs may attenuate peritoneal injury by repairing mesothelial cells, reducing inflammation and fibrosis and rather than the engraftment, the secretion of TSG-6 by M SCs makes a major contribution to the therapeutic benefits of MSCS.

TL;DR: In vivo and in vitro experiments demonstrate that podocyte injury is associated with changes in autophagy levels, and that rapamycin can reduce podocytes injury by increasing autophagic levels via inhibition of the mTOR-ULK1 pathway.

TL;DR: It is identified that the absence of DR, shorter duration of DM, lower HbA1C, and lower BP may help to distinguish NDRD from DN in patients with diabetes.

TL;DR: In this paper, a new differential diagnostic model was proposed for Type 2 diabetes using Logistic regression, receiver operating characteristics (ROC) curve, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) analysis.

TL;DR: Flos A. manihot may be considered as an important adjunctive therapy with the first-line and indispensable therapeutic strategies for type 2 DN and high-quality RCTs are urgently needed to confirm the effect of Flo A.Manihot on definite endpoints such as end-stage renal disease.